Guilin Sanjin Pharmaceutical Co., Ltd. (SHE:002275)
China · Delayed Price · Currency is CNY 14.27
-0.02 (-0.14%)
At close: Feb 3, 2026
SHE:002275 Revenue
Guilin Sanjin Pharmaceutical had revenue of 464.04M CNY in the quarter ending September 30, 2025, a decrease of -8.36%. This brings the company's revenue in the last twelve months to 2.08B, down -1.56% year-over-year. In the year 2024, Guilin Sanjin Pharmaceutical had annual revenue of 2.19B with 1.03% growth.
Revenue (ttm)
2.08B
Revenue Growth
-1.56%
P/S Ratio
4.03
Revenue / Employee
810.90K
Employees
2,567
Market Cap
8.40B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 2.19B | 22.39M | 1.03% |
| Dec 31, 2023 | 2.17B | 211.87M | 10.81% |
| Jan 1, 2023 | 1.96B | 218.51M | 12.55% |
| Jan 1, 2022 | 1.74B | 174.74M | 11.15% |
| Dec 31, 2020 | 1.57B | -73.94M | -4.51% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full Definition